Maize C. Cao
3A Symonds Street
Auckland, AUK 1010, New Zealand
Auckland, AUK 1010, New Zealand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Statins and genetic inhibition of the mevalonate pathway activate an ATF3-STMN2 regenerative program.
Journal: bioRxiv : the preprint server for biology
Published: April 29, 2026
Lost in translation: absence of KIAA1324/ELAPOR1 protein in pathological TDP-43-affected neurons in ALS/FTD.
Journal: Acta neuropathologica communications
Published: August 18, 2025
Synaptic changes contribute to persistent extra-motor behaviour deficits in amyotrophic lateral sclerosis.
Journal: Acta neuropathologica communications
Published: May 18, 2025
A panel of TDP-43-regulated splicing events verifies loss of TDP-43 function in amyotrophic lateral sclerosis brain tissue.
Journal: Neurobiology of disease
Published: May 11, 2023
Microglial CD68 and L-ferritin upregulation in response to phosphorylated-TDP-43 pathology in the amyotrophic lateral sclerosis brain.
Journal: Acta neuropathologica communications
Published: February 16, 2023
Transcriptional targets of amyotrophic lateral sclerosis/frontotemporal dementia protein TDP-43 - meta-analysis and interactive graphical database.
Journal: Disease models & mechanisms
Published: December 08, 2021
The amyotrophic lateral sclerosis-linked protein TDP-43 regulates interleukin-6 cytokine production by human brain pericytes.
Journal: Molecular and cellular neurosciences
Published: April 13, 2021
Motor neuron disease mortality rates in New Zealand 1992-2013.
Journal: Amyotrophic lateral sclerosis & frontotemporal degeneration
Published: February 01, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026